Hung David
SEC-identified person · CIK 1310880 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Novocure Ltd NVCR | Director | filed 2018–2026 |
| Panacea Acquisition Corp PANA | Director · President and CEO | filed 2021–2026 |
| Arya Sciences Acquisition Corp. ARYA | Director | filed 2018–2020 |
| Establishment Labs Holdings INC. ESTA | Director | filed 2018–2020 |
| Sio Gene Therapies Inc. SIOX | Director · Principal Executive Officer | filed 2017–2018 |
| Medivation, INC. MDVN.OB | Director · President and CEO | filed 2006–2016 |
| Pharmafrontiers Corp. pftr.ob | Director | filed 2006–2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.